COVID-19 May Increase Risk for Adverse Pregnancy Outcomes
COVID-19 is associated with increased risks for preeclampsia, preterm birth, and other adverse pregnancy outcomes.
Pregnancy
First-Trimester Prescription Opioids Not Linked to Most Developmental Malformations
The objective of this study was to evaluate the risks of first-trimester exposure to prescription opioids for major congenital malformations.
Opioid Use in Early Pregnancy Not Tied to Most Birth Defects
Opioid use in early pregnancy is associated with a small increase in risk for cleft palate but no increase in risk for most major congenital malformations.
Rates of Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses Increase
From 2010 to 2017, there were significant increases in the estimated rates of neonatal abstinence syndrome and maternal opioid-related diagnoses.
Opioids and Psychotropic Medication Frequently Coprescribed During Pregnancy
Opioid coprescription with psychotropic medications during pregnancy increases a woman’s antepartum hospitalization risk.
Self-Reported Prescription Opioid Use During Pregnancy
The CDC analyzed prescription opioid use during pregnancy via a self-reported survey.
Managing Migraine During Pregnancy and Lactation
A particular challenge in this population is the effective management of migraine during pregnancy and lactation while minimizing the risk for harm to the fetus.
The Impact of Prenatal Opioid Exposure on Cognitive, Motor Development
Prenatal opioid exposure may be associated with poorer cognitive and motor development in children from age 6 months to adolescence.
Managing Migraine During Pregnancy and Lactation
A particular challenge in this population is the effective management of migraine during pregnancy and lactation while minimizing the risk for harm to the fetus.
Adverse Outcomes Up for Pregnant Women With Migraine
Increased risk for several neonatal, postnatal outcomes for offspring exposed to maternal migraine
-
Loading...
-
Loading...
Next post in Migraine & Headache
